BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25075145)

  • 1. Molecular profiling of gliomas--time for a regional service.
    Hannan C; Al-Rashid S; Herron B; Conkey D; Harney J; Lyness J; Moss J; Flannery T
    Ulster Med J; 2014 May; 83(2):120-1. PubMed ID: 25075145
    [No Abstract]   [Full Text] [Related]  

  • 2. How molecular testing can help (and hurt) in the workup of gliomas.
    Clark K; Voronovich Z; Horbinski C
    Am J Clin Pathol; 2013 Mar; 139(3):275-88. PubMed ID: 23429363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs might be promising biomarkers of human gliomas.
    Wang H; Yuan X; Zhou Z; Hu J; Zhang T; Hu S; Luo J; Li X
    Asian Pac J Cancer Prev; 2011; 12(4):833-5. PubMed ID: 21790212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
    Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
    Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-oncology: Implications of the molecular era.
    Ruff MW; Uhm JH; Benarroch EE
    Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritizing uncharacterized genes in the search for glioma biomarkers.
    Towner RA; Wren JD
    CNS Oncol; 2014 Mar; 3(2):93-5. PubMed ID: 25055012
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of molecular biology studies on the understanding of brain tumors in childhood.
    Nageswara Rao AA; Packer RJ
    Curr Oncol Rep; 2012 Apr; 14(2):206-12. PubMed ID: 22237928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliomas: advances in molecular analysis and characterization.
    Boudreau CR; Yang I; Liau LM
    Surg Neurol; 2005 Oct; 64(4):286-94; discussion 294. PubMed ID: 16229087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers usher in era of personalized care for malignant glioma patients.
    Chakravarti A; Palanichamy K; Bell EH
    CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteomic analysis of gliomas.
    Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
    Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs: Functions and Prospects in Glioma.
    Hao Z; Hu S; Liu Z; Song W; Zhao Y; Li M
    J Mol Neurosci; 2019 Jan; 67(1):72-81. PubMed ID: 30460608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists.
    Kim H; Kim S; Lee HH; Heo H
    Korean J Radiol; 2016; 17(5):620-32. PubMed ID: 27587950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnostics of gliomas: state of the art.
    Riemenschneider MJ; Jeuken JW; Wesseling P; Reifenberger G
    Acta Neuropathol; 2010 Nov; 120(5):567-84. PubMed ID: 20714900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on molecular biomarkers and classification of malignant gliomas.
    Zhang C; Bao Z; Zhang W; Jiang T
    Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma.
    Fan Z; Liu Y; Li S; Liu X; Jiang T; Wang Y; Wang L
    Aging (Albany NY); 2020 May; 12(9):7908-7926. PubMed ID: 32388499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs as efficient biomarkers in high-grade gliomas.
    Barciszewska AM
    Folia Neuropathol; 2016; 54(4):369-374. PubMed ID: 28139816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
    Martinho O; Granja S; Jaraquemada T; Caeiro C; Miranda-Gonçalves V; Honavar M; Costa P; Damasceno M; Rosner MR; Lopes JM; Reis RM
    PLoS One; 2012; 7(1):e30769. PubMed ID: 22292035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and treatment of gliomas.
    Janus TJ; Kyritsis AP; Forman AD; Levin VA
    Ann Oncol; 1992 Jun; 3(6):423-33. PubMed ID: 1498059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.